Adjuvant Capital, a NY-based firm, is a life sciences investment company established to finance the development of drugs, vaccines, diagnostics, medical devices, and other technologies for public health challenges that disproportionately burden low-and middle-income countries.
Venture Capital
1 funds found in our dataset.
Built for investment teams that need to move faster.
Intelligently process data room financials, generate auditable analyses, and export IC-ready deliverables.